Your browser doesn't support javascript.
loading
Evaluation of plasminogen activator inhibitor-1 as a biomarker of unplanned revascularization and major adverse cardiac events in coronary angiography and percutaneous coronary intervention.
Jung, Richard G; Simard, Trevor; Di Santo, Pietro; Dhaliwal, Shan; Sypkes, Caleb; Duchez, Anne-Claire; Moreland, Robert; Taylor, Katlyn; Parlow, Simon; Visintini, Sarah; Labinaz, Alisha; Marbach, Jeffrey; Sarathy, Kiran; Bernick, Jordan; Joseph, Joanne; Boland, Paul; Abdel-Razek, Omar; Harnett, David T; Ramirez, F Daniel; Hibbert, Benjamin.
Afiliação
  • Jung RG; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottaw
  • Simard T; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottaw
  • Di Santo P; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; School o
  • Dhaliwal S; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ot
  • Sypkes C; Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
  • Duchez AC; Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
  • Moreland R; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Taylor K; Department of Pharmacy, The Ottawa Hospital, Ottawa, Ontario, Canada.
  • Parlow S; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division
  • Visintini S; Berkman Library, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
  • Labinaz A; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
  • Marbach J; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
  • Sarathy K; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
  • Bernick J; Ottawa Cardiovascular Research Methods Center, Ottawa, Ontario, Canada.
  • Joseph J; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Internal Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada.
  • Boland P; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
  • Abdel-Razek O; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
  • Harnett DT; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
  • Ramirez FD; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Hôpital Cardiologique du Haut-Lévêque, CHU Bordeaux, Bordeaux-Pessac, France; L'Institut de Rythmologie et Modélisation Cardia
  • Hibbert B; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottaw
Thromb Res ; 191: 125-133, 2020 07.
Article em En | MEDLINE | ID: mdl-32447094
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Angiografia Coronária / Inibidor 1 de Ativador de Plasminogênio / Intervenção Coronária Percutânea Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Thromb Res Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Angiografia Coronária / Inibidor 1 de Ativador de Plasminogênio / Intervenção Coronária Percutânea Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Thromb Res Ano de publicação: 2020 Tipo de documento: Article